U.S. stocks were edging lower on Friday, as investors waited on a monthly jobs number that could help determine if the Federal Reserve has any scope to cut interest rates this year.
Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...